| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10588739 | Bioorganic & Medicinal Chemistry Letters | 2011 | 7 Pages |
Abstract
The discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly is described. Synthesis of analogs of the 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione hit established structure-activity relationships. Replacement of the enamine functionality of the hit series with either an imidazole or a pyrazole ring led to compounds that inhibited both capsid assembly and reverse transcriptase. Optimization of the bicyclic benzodiazepine scaffold to include a 3-phenyl substituent led to lead compound 48, a pure capsid assembly inhibitor with improved antiviral activity.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Lee D. Fader, Richard Bethell, Pierre Bonneau, Michael Bös, Yves Bousquet, Michael G. Cordingley, René Coulombe, Patrick Deroy, Anne-Marie Faucher, Alexandre Gagnon, Nathalie Goudreau, Chantal Grand-Maître, Ingrid Guse, Oliver Hucke, Stephen H. Kawai,
![First Page Preview: Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly](/preview/png/10588739.png)